Armistice Capital, Llc - Dec 31, 2024 SCHEDULE 13G/A Report for TRAVERE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TVTX)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: TRAVERE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share
Symbol: TVTX
Shares outstanding: 76.5M shares
Disclosed Ownership: 7.36M shares
Ownership: 9.62%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 05:22 PM
Date of event: Dec 31, 2024
Next filing: May 15, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	9.62%	7.36M	0	7.36M	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	9.62%	7.36M	0	7.36M	/s/ Steven Boyd	Steven Boyd